Oric Pharmaceuticals (ORIC) Insider Trading & Ownership $9.63 -0.25 (-2.53%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$9.63 0.00 (0.00%) As of 08:25 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Oric Pharmaceuticals (NASDAQ:ORIC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.82%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$262.98KNumber OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$767.04K Get ORIC Insider Trade Alerts Want to know when executives and insiders are buying or selling Oric Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORIC Insider Buying and Selling by Quarter Oric Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/24/2025Dominic PiscitelliCFOSell32,466$10.50$340,893.00 6/23/2025Angie YouDirectorBuy1,403$9.43$13,230.29 6/23/2025Dominic PiscitelliCFOSell1,034$10.00$10,340.00 6/20/2025Angie YouDirectorBuy26,597$9.39$249,745.83 6/12/2025Dominic PiscitelliCFOSell300$10.00$3,000.00 6/11/2025Dominic PiscitelliCFOSell2,976$10.01$29,789.76 6/10/2025Dominic PiscitelliCFOSell324$10.00$3,240.00 6/9/2025Dominic PiscitelliCFOSell300$10.00$3,000.00 6/6/2025Dominic PiscitelliCFOSell2,600$10.01$26,026.00 12/16/2024Dominic PiscitelliCFOSell8,851$8.28$73,286.28 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 12/16/2024Jacob ChackoCEOSell24,660$8.28$204,184.80 12/16/2024Pratik S MultaniInsiderSell8,850$8.28$73,278.00 (Data available from 1/1/2013 forward) ORIC Insider Trading Activity - Frequently Asked Questions Who is on Oric Pharmaceuticals' Insider Roster? The list of insiders at Oric Pharmaceuticals includes Angie You, Dominic Piscitelli, Jacob Chacko, and Pratik S Multani. Learn more on insiders at ORIC. What percentage of Oric Pharmaceuticals stock is owned by insiders? 6.82% of Oric Pharmaceuticals stock is owned by insiders. Learn more on ORIC's insider holdings. Which Oric Pharmaceuticals insiders have been buying company stock? The following insider purchased ORIC shares in the last 24 months: Angie You ($262,976.12). How much insider buying is happening at Oric Pharmaceuticals? Insiders have purchased a total of 28,000 ORIC shares in the last 24 months for a total of $262,976.12 bought. Which Oric Pharmaceuticals insiders have been selling company stock? The following insiders have sold ORIC shares in the last 24 months: Dominic Piscitelli ($489,575.04), Jacob Chacko ($498,100.38), and Pratik S Multani ($118,650.38). How much insider selling is happening at Oric Pharmaceuticals? Insiders have sold a total of 116,140 Oric Pharmaceuticals shares in the last 24 months for a total of $1,106,325.80 sold. Oric Pharmaceuticals Key ExecutivesDr. Richard A. Heyman Ph.D. (Age 67)Co-Founder, Independent Chairman & Member of Scientific Advisory Board Compensation: $93kDr. Jacob M. Chacko M.B.A. (Age 45)M.D., President, CEO & Director Compensation: $961kMr. Dominic G. Piscitelli CPA (Age 49)M.B.A., Chief Financial Officer Compensation: $654.74k7 recent tradesDr. Pratik S. Multani M.D. (Age 57)M.S., Chief Medical Officer Compensation: $715.22kDr. Charles L. Sawyers B.A. (Age 65)M.D., Ph.D., Co-Founder & Member of Scientific Advisory Board Dr. Scott W. Lowe Ph.D.Co-Founder & Member of Scientific Advisory BoardDr. Lori Sickels Friedman Ph.D. (Age 60)Chief Scientific Officer Dr. Christian V. Kuhlen Esq. (Age 51)J.D., M.D., General Counsel Mr. Daniel IazzettiVP & Head of PeopleDr. Edna Chow Maneval (Age 64)Senior Vice President of Clinical Development More Insider Trading Tools from MarketBeat Related Companies ACADIA Pharmaceuticals Insider Buying Viking Therapeutics Insider Buying Scholar Rock Insider Buying PTC Therapeutics Insider Buying SpringWorks Therapeutics Insider Buying MoonLake Immunotherapeutics Insider Buying Protagonist Therapeutics Insider Buying Kymera Therapeutics Insider Buying Crinetics Pharmaceuticals Insider Buying Immunovant Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NASDAQ:ORIC) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe Coin That Could Define Trump’s Crypto PresidencyWhen Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top ad...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
